Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease-Reference-Cited by-同舟云学术

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

Published:1996-02 Issue:2 Volume:47 Page:236-239
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Zietman Anthony L.,Dallow Katherine C.,McManus Patricia A.,Heney Niall M.,Shipley William U.

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. and future;Zietman;Semin Radiat Oncol,1993

2. Extended field (periaortic) irradiation in carcinoma of the prostate-analysis of RTOG 75-06;Pilepich;Int J Radiat Oncol Biol Phys,1986

3. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07;Pilepich;Int J Radiat Oncol Biol Phys,1989

4. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformai protons compared with conventional dose irradiation using photons alone;Shipley;Int J Radiat Oncol Biol Phys,1995

5. Surrogate markers in AIDS and cancer trials;Fleming;Stat Med,1994

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival;European Urology;2018-10

2. Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy;Medical Oncology;2014-06-10

3. Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study;World Journal of Urology;2013-11-24

4. Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy;Journal of Urology;2013-11

5. Clinical Advances by the MGH Department of Radiation Oncology;Evolution of Radiation Oncology at Massachusetts General Hospital;2010-11-25